|
| |
|
DRUG |
BRAND NAME |
INDICATIONS
|
DAILY DOSE
(MG/KG) |
DAILY
DOSAGE
SCHEDULE |
ADVERSE
EFFECTS |
PREPARATIONS AVAILABLE |
|
METHYLPHENIDATE |
RITALIN |
ADHD +
COMORBIDITY/
DEVELOPMENTAL DISABILITIES
ADJUNCT Tx
IN REFRACTORY DEPRESSION |
0.3 - 2.0 |
TWO OR
THREE TIMES |
INCREASE
IN HEART RATE AND BLOOD PRESSURE (MILD);
POSSIBLE
REDUCTION IN GROWTH VELOCITY WITH LONG-TERM USE;
WITHDRAWAL
EFFECTS AND REBOUND PHENOMENA;
RARELY,
TIC DISORDERS |
RITALIN
5, 10, 20
MG
SUSTAINED
RELEASE 20 MG
CONCERTA,
18mg. 36 mg, 54 mg.
|
|
MAGNESIUM
PEMOLINE
|
CYLERT |
AS ABOVE |
1.0 - 3.0 |
ONCE |
SAME AS
OTHER STIMULANTS;
ABNORMAL
LIVER FUNCTION TESTS |
18.75,
37.5, 75 MG |
|
DEXTROAMPHETAMINE |
DEXEDRINE
ADDERALL |
ADHD
ADHD |
0.3 - 1.5
2.5 start
dose Preschool
5 mg
school age
.3 - 1.5
mg Maximum dose
Per kg
body weight |
TWICE OR
THREE TIMES
TWICE OR
THREE
TIMES
Rarely to
exceed 40mg/day |
INSOMNIA,
WEIGHT LOSS, HEADACHE,
DECREASED
APPETITE, NERVOUSNESS, DIZZINESS, RARELY, TIC DISORDERS, PSYCHOSIS (May be
Induced by high doses)
INSOMNIA,
WEIGHT LOSS, UPSET STOMACH,
DECREASED
APPETITE, UNPLEASANT TASTE,
WEIGHT
LOSS, CONSTIPATION, NERVOUSNESS,
TREMORS,
RESTLESSNESS, DIZZINESS, RARELY, TIC DISORDERS
PSYCHOSIS
(May be induced by highdoses) |
DEXEDRINE:
5 MG;
SUSTAINED
RELEASE 5, 10,
15 MG
2.5, 7.5,
10MG
5, 15,
20MG
10, 30,
40MG
15, 45,
60MG
|
|
DRUG |
BRAND NAME |
MAIN
INDICATIONS
|
DAILY DOSE
(MG/KG) |
DAILY
DOSAGE
SCHEDULE |
ADVERSE
EFFECTS |
PREPARATIONS AVAILABLE |
|
BUPROPION |
WELLBUTRIN |
ADHD
MDD |
3-6 MG/KG |
THREE
TIMES |
IRRITABILITY
INSOMNIA
DRUG
INDUCED SEIZURES
(IN DOSES
> 6 MG/KG)
CONTRAINDICATED IN BULIMICS |
75, 100 MG |
|
SELECTIVE
SEROTONIN REUPTAKE INHIBITORS (SSRIs)
FLUOXETINE
SERTRALINE
PAROXETINE
FLUVOXAMINE |
PROZAC
ZOLOFT
PAXIL
LUVOX |
MDD
OCD
ANXIETY |
0.5-1.0
1.5-3.0
0.25-0.70
1.5-4.5 |
ONCE IN
THE AM |
IRRITABILITY
INSOMNIA
GI
SYMPTOMS
HEADACHES |
FLUOXETINE
10, 20
MG, ELIXIR
SERTRALINE
50, 100
MG
PAROXETINE
20, 30 MG
FLUVOXAMINE
50, 100
MG |
|
TRAZADONE |
DESYREL |
MDD
AGGRESSION
INSOMNIA |
2-5 MG/KG |
TWO TIMES |
ORTHOSTATIC HYPOTENSION
PRIAPISM
SEDATION |
50, 100,
150, 300 MG |
|
VENLAFAXINE |
EFFEXOR |
MDD
OCD
ANXIETY |
1-3 MG/KG |
TWICE,
THREE TIMES |
SIMILAR TO
SSRIs
NAUSEA,
SLEEPINESS, DIZZINESS,
SUSTAINED
DIASTOLIC HYPERTENSION |
25, 37.5,
50, 75,
100 MG
|
|
DRUG |
BRAND NAME |
MAIN
INDICATIONS
|
DAILY DOSE
(MG/KG) |
DAILY
DOSAGE
SCHEDULE |
ADVERSE
EFFECTS |
PREPARATIONS AVAILABLE |
|
TRICYCLICS
(TCA)
IMIPRAMINE
DESIPRAMINE
NORTRIPTYLINE |
TOFRANIL
NORPRAMIN
PAMELOR |
MDD
ENURESIS
ADHD
TIC
DISORDER
+OCD
ANXIETY
DISORDERS |
2.0-5.0
(1.0-3.0
FOR NORTRIPTYLINE)
DOSE
ADJUSTED
ACCORDING
TO SERUM LEVELS
(THERAPEUTIC WINDOW FOR NORTRIPTYLINE) |
ONCE OR
TWICE |
ANTICHOLINERGIC (DRY MOUTH, CONSTIPATION, BLURRED VISION)
WEIGHT LOSS
CARDIOVASCULAR (MILD INCREASE) DIASTOLIC BLOOD PRESSURE AND ECG CONDUCTION
PARAMETERS WITH DAILY DOSES > 3.5 MG/KG.
TREATMENT
REQUIRES SERUM LEVELS AND ECG MONITORING |
IMIPRAMINE
HYDROCHLORIDE
10, 25, 50
MG
IMIPRAMINE
PAMOATE
75,
100, 125,
150 MG
DESIPRAMINE
10, 25,
50, 75,
100, 150 MG
NORTRIPTYLINE
10,
25, 50, 75
MG
ELIXIR |
|
CLOMIPRAMINE |
ANAFRANIL |
OCD |
2.0-3.0 |
ONCE OR
TWICE |
NO KNOWN
LONG TERM SIDE EFFECTS
WITHDRAWAL
EFFECTS CAN OCCUR (SEVERE GASTROINTESTINAL SYMPTOMS, MALAISE)
OVERDOSES
CAN BE FATAL |
25, 50, 75
MG |
|
NON
SELECTIVE MONOAMINE OXIDASE-A/B INHIBITORS (MAOIs)
PHENELZINE
TRANYLCYPROMINE |
NARDIL
PARNATE |
MDD
ATYPICAL
DEPRESSION
ADHD
ANXIETY
DISORDERS |
0.5-1.0
MG/KG |
TWICE,
THREE TIMES |
SEVERE
DIETARY RESTRICTIONS (HIGH TYRAMINE FOODS) HYPERTENSIVE CRISIS WITH
DIETETIC TRANSGRESSION OR WITH CERTAIN DRUGS
WEIGHT
GAIN
DROWSINESS
CHANGES IN
BLOOD PRESSURE
INSOMNIA
LIVER
TOXICITY (REMOTE) |
PHENELZINE
15 MG
TRANYLCYPROMINE
10 MG |
|
DRUG |
BRAND NAME |
MAIN
INDICATIONS
|
DAILY DOSE
(MG/KG) |
DAILY
DOSAGE
SCHEDULE |
ADVERSE
EFFECTS |
PREPARATIONS AVAILABLE |
|
SELECTIVE
MONOAMINE OXIDASE-B INHIBITOR
SELEGILINE |
DEPRENYL |
ADHD IN
TOURETTEs SYNDROME |
70-214
MCG/KG
<
15 MG |
TWICE
(AM, NOON) |
TYRAMINE
REACTION
(HYPERTENSIVE CRISIS WITH DIETETIC TRANSGRESSION OR WITH CERTAIN DRUGS) MAY
OCCUR AT HIGH DOSES
NAUSEA
DIZZINESS
CHANGES IN
BLOOD PRESSURE |
5 MG
|
|
DRUG |
BRAND NAME |
MAIN
INDICATIONS
|
DAILY DOSE
(MG/KG) |
DAILY
DOSAGE
SCHEDULE |
ADVERSE
EFFECTS |
PREPARATIONS AVAILABLE |
|
NORADRENERGIC AGENTS |
|
|
|
|
|
|
|
CLONIDINE
NON
SPECIFIC ALPHA-2 AGONIST |
CATAPRES |
TOURETTEs
DISORDER
ADHD
AGGRESSION/
SELF ABUSE
ANXIETY
DISORDERS
ADJUNCT IN
MANIA AND SCHIZOPHRENIA
WITHDRAWAL
SYNDROMES |
3-10
MCG/KG |
TWICE OR
THREE TIMES |
SEDATION
(VERY FREQUENT)
HYPOTENSION (RARE)
DRY MOUTH
CONFUSION
(WITH HIGH DOSE)
DEPRESSION
REBOUND
HYPERTENSION
LOCALIZED
IRRITATION WITH TRANSDERMAL PREPARATION
|
0.1, 0.2,
0.3 MG
TRANSDERMAL
PATCH |
|
GUANFACINE
(SELECTIVE
ALPHA-2A AGONIST) |
TENEX |
TOURETTEs
DISORDER
ADHD |
15-43
MCG/KG |
ONCE OR
TWICE |
SAME AS
CLONIDINE
LESS
SEDATION, HYPOTENSION |
1.2 MG |
|
PROPRANOLOL
(B-BLOCKER) |
INDERAL |
TOURETTEs
DISORDER
ADHD
AGGRESSION/
SELF ABUSE
SEVERE
AGITATION
AKATHISIA |
2-8 MG/KG |
TWICE |
SIMILAR TO
CLONIDINE
HIGHER
RISK FOR BRADYCARDIA AND HYPOTENSION (DOSE DEPENDENT) AND REBOUND
HYPERTENSION
BRONCHOSPASM
(CONTRAINDICATED IN ASTHMATICS)
REBOUND
HYPERTENSION ON ABRUPT WITHDRAWAL |
10, 20,
40, 60, 80 MG
LONG-ACTING
60, 80,
120, 160 MG |
|